Articles

Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib

University of California at San Francisco, CA, USA
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, USA
M.D. Anderson Cancer Center, Houston, TX, USA
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Department of Genetics and Molecular Pathology, SA Pathology, and University of Adelaide, Australia
Department of Genetics and Molecular Pathology, SA Pathology, and University of Adelaide, Australia
M.D. Anderson Cancer Center, Houston, TX, USA
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, USA
Vol. 99 No. 11 (2014): November, 2014 https://doi.org/10.3324/haematol.2013.085977